RNASEH2B loss and PARP inhibition in advanced prostate cancer.
Carmichael J, Figueiredo I, Gurel B, Beije N, Yuan W, Rekowski J, Seed G, Carreira S, Bertan C, Fenor de La Maza MLD, Chandran K, Neeb A, Welti J, Gallagher L, Bogdan D, Crespo M, Riisnaes R, Ferreira A, Miranda S, Lu J, Shen MM, Hall E, Porta N, Westaby D, Guo C, Grochot R, Lord CJ, Mateo J, Sharp A, de Bono J.
Carmichael J, et al. Among authors: shen mm.
J Clin Invest. 2024 Jun 4;134(21):e178278. doi: 10.1172/JCI178278.
J Clin Invest. 2024.
PMID: 38833311
Free PMC article.
Clinical Trial.